Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Bone Marrow Transplant in Chronic Insulin Dependent Diabetic Patients Phase II Clinical Trial. Version: 1.3 - January 13, 2016

NCT03562208 is registered in ClinicalTrials.gov with Global Cell Med as lead sponsor.

NCT NCT03562208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03562208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Bone Marrow Transplant in Chronic Insulin Dependent Diabetic Patients Phase II Clinical Trial. Version: 1.3 - January 13, 2016
Lead sponsor
Global Cell Med
Phase
Phase 2/3
Overall status
Unknown status
Start date
January 1, 2018
Completion date
June 30, 2020
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes complications, diabetes mellitus progression